Aducanumab- a Drug of hope for the elderly
Madam, Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by impaired cognitive functions in a person (1). It is the most common cause of dementia and a major cause of morbidity and mortality in the elderly. Currently, 50 million people in the world live with dementi...
Main Authors: | Muhammad Kashan Zaheer, Wajiha Siddiqi, Ghana Raza |
---|---|
Format: | Article |
Language: | English |
Published: |
Pakistan Medical Association
2022-04-01
|
Series: | Journal of the Pakistan Medical Association |
Online Access: | https://www.ojs.jpma.org.pk/index.php/public_html/article/view/4418 |
Similar Items
-
Aducanumab—Hope or Disappointment for Alzheimer’s Disease
by: Karolina Wojtunik-Kulesza, et al.
Published: (2023-02-01) -
Aducanumab: an uprising hope with vague horizons
by: Delara Hazegh Fetratjoo, et al.
Published: (2023-06-01) -
Hope or hype? Aducanumab as a magic bullet for Alzheimer’s disease
by: Wei-Jye Lin, et al.
Published: (2022-06-01) -
Is Aducanumab for LMICs? Promises and Challenges
by: Illangage P. C. Gunawardena, et al.
Published: (2021-11-01) -
An insider's perspective on FDA approval of aducanumab
by: Yaning Wang
Published: (2023-04-01)